Tranexamic Acid Cuts Surgical Bleeding in Yet Another Setting

(MedPage Today) -- A dose of tranexamic acid to start and end noncardiac surgery reduced important bleeding events, the POISE-3 trial showed, albeit with a question mark hanging over cardiovascular risk. The antifibrinolytic drug cut life-threatening...
Source: MedPage Today Surgery - Category: Surgery Source Type: news